Dynavax Purchase (Details) - Dynavax Technologies $ in Millions |
1 Months Ended | 6 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|---|
|
Aug. 31, 2023
USD ($)
|
Jun. 30, 2022
USD ($)
|
Sep. 30, 2021
USD ($)
|
Jun. 30, 2026
USD ($)
milestone
|
Dec. 31, 2020
USD ($)
upfrontPayment
|
|
| Asset Acquisition [Line Items] | |||||
| Number of upfront payment | upfrontPayment | 1 | ||||
| Upfront payment | $ 9.0 | ||||
| Payments for milestone | $ 1.0 | $ 1.0 | $ 1.0 | ||
| Number of commercial milestones | milestone | 4 | ||||
| Maximum aggregate milestone payments per development milestone | $ 170.0 | ||||
| Royalties as a percentage of net sales, under sales threshold | 0.10 | ||||
| Royalties, sales threshold amount | $ 1,000.0 | ||||
| Royalties as a percentage of sales, over threshold amount | 0.12 | ||||
| Commercial Milestone | |||||
| Asset Acquisition [Line Items] | |||||
| Maximum aggregate milestone payments per development milestone | $ 80.0 | ||||
| Minimum | |||||
| Asset Acquisition [Line Items] | |||||
| Payments for milestone | 1.0 | ||||
| Maximum | |||||
| Asset Acquisition [Line Items] | |||||
| Payments for milestone | $ 10.0 | ||||